Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.

Endovascular grafts recalled due to risk of coating breaking off, entering bloodstream
Customers are urged to examine their inventory, quarantine any unused products and return them to the manufacturer.
FDA finalizes Class I recall for Medtronic catheters
There is a risk that these catheters will fail to retain their shape during use, causing procedure delays and creating the risk of an adverse outcome. The FDA first warned users about the issue back in August.
FDA confirms new recall for Johnson & Johnson heart device over safety concerns
Three patient deaths have been linked to connectivity issues with these devices. The FDA has classified this as a Class I recall.
Hospital lost patient’s skull, offered $25 gas card as recompense, lawsuit claims
Edna Burton underwent a hemicraniectomy to alleviate pressure on her brain after a stroke. When it came time to put an extracted piece of her skull back in place, her family alleges a Detroit hospital was forced to use a prosthetic, having lost the original. They said administrators offered a $25 gasoline card as an apology.
Medtronic’s diabetes spin-off files for IPO
Make way for MiniMed! Medtronic's diabetes division has filed the necessary paperwork to go public. The company hopes to be traded on Nasdaq under the symbol MMED.

Cook Medical endovascular grafts recalled due to risk of coating breaking off, entering patient’s bloodstream.

Endovascular grafts recalled due to risk of coating breaking off, entering bloodstream

Customers are urged to examine their inventory, quarantine any unused products and return them to the manufacturer.

FDA finalizes Class I recall for Medtronic catheters

There is a risk that these catheters will fail to retain their shape during use, causing procedure delays and creating the risk of an adverse outcome. The FDA first warned users about the issue back in August.

FDA recall medical device recall product recall

FDA confirms new recall for Johnson & Johnson heart device over safety concerns

Three patient deaths have been linked to connectivity issues with these devices. The FDA has classified this as a Class I recall.

statue justice legal verdict malpractice case lawsuit scale

Hospital lost patient’s skull, offered $25 gas card as recompense, lawsuit claims

Edna Burton underwent a hemicraniectomy to alleviate pressure on her brain after a stroke. When it came time to put an extracted piece of her skull back in place, her family alleges a Detroit hospital was forced to use a prosthetic, having lost the original. They said administrators offered a $25 gasoline card as an apology.

Medtronic’s MiniMed 780G automated insulin delivery system

Medtronic’s diabetes spin-off files for IPO

Make way for MiniMed! Medtronic's diabetes division has filed the necessary paperwork to go public. The company hopes to be traded on Nasdaq under the symbol MMED.

Advances in intravascular imaging and physiology assessment are reshaping how interventional cardiologists plan and optimize percutaneous coronary interventions (PCI), but workflow challenges continue to limit adoption, according to Haroon Faraz, MD, director of interventional cardiology and cardiovascular research at Hackensack University Medical Center.

New strategies for intravascular imaging and physiological assessments in the cath lab

"If you're not using an intravascular imaging modality, the PCI is not optimal," explained Haroon Faraz, MD, from Hackensack University Medical Center. Faraz is hopeful new and improved technologies will help these modalities become more popular among interventional cardiologists.

warning safety alert recall healthcare issue

Bleeding reversal agent pulled from market over FDA’s safety concerns

AstraZeneca has stopped selling Andexxa because randomized data suggested some patients may face an increased risk of certain adverse events. The company emphasized that it remains confident in the agent's abilities.

Abbott PFA system gains FDA approval

The Volt Pulsed Field Ablation System from Abbott has been approved by the FDA. The technology, which gained CE mark approval in March, features a one-of-a-kind catheter design and allows patients to be treated under conscious sedation.